Safety of azithromycin in infants under six months of age in Niger: A community randomized trial.

• Үндсэн зохиолчид: Catherine E Oldenburg (Зохиогч), Ahmed M Arzika (Зохиогч), Ramatou Maliki (Зохиогч), Mohamed Salissou Kane (Зохиогч), Elodie Lebas (Зохиогч), Kathryn J Ray (Зохиогч), Catherine Cook (Зохиогч), Sun Y Cotter (Зохиогч), Zhaoxia Zhou (Зохиогч), Sheila K West (Зохиогч), Robin Bailey (Зохиогч), Travis C Porco (Зохиогч), Jeremy D Keenan (Зохиогч), Thomas M Lietman (Зохиогч), MORDOR Study Group (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Public Library of Science (PLoS), 2018-11-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

BACKGROUND:Mass azithromycin distribution reduces under-5 child mortality. Trachoma control programs currently treat infants aged 6 months and older. Here, we report findings from an infant adverse event survey in 1-5 month olds who received azithromycin as part of a large community-randomized trial...